Daily non-political popular news in brief.

Popular osteoporosis drugs triple risk of bone necrosis

01-15-2008 · EurekAlert!

A University of British Columbia and Vancouver Coastal Health Research Institute study has found that a popular class of osteoporosis drugs nearly triples the risk of developing bone necrosis, a condition that can lead to disfigurement and incapacitating pain.

Keywords: popular, osteoporosis, drugs, triple, risk, bone, necrosis, osteoporosi, drug, necrosi

« Previous | Next »

Similar news on "Popular osteoporosis drugs triple risk of bone necrosis":

Bad to the Bone: Acid stoppers appear to have a downside
01-06-2007 · Science News Online
Popular acid-reducing drugs called proton-pump inhibitors may increase the risk of hip fractures in people over 50.
Similar news · Read more »
Annals of Internal Medicine tip sheet for March 20, 2007
03-19-2007 · EurekAlert!
The following articles are featured in the upcoming Annals of Internal Medicine: "Flexible Use of Drugs with Close Patient Follow-up Can Successfully Control Rheumatoid Arthritis;" "Osteoporosis Drug Strengthens Bones in Men with Prostate Cancer," and "Experts Show Physicians How to Initiate and Carry Through Timely and Effective Discussions about Hospice with Dying Patients."
Similar news · Read more »
Women up to age 30 at risk for bone loss, study finds
06-04-2007 · EurekAlert!
Women who follow strict exercise and diet regimens may harm their body's ability to form new bone, which can lead to osteoporosis later in life. Researchers recommend that the more women exercise, the more they need to eat to stay healthy.
Similar news · Read more »
Alendronate can help prevent bone fractures in many postmenopausal women
01-22-2008 · EurekAlert!
Giving 10mg per day of the bisphosphate drug alendronate to women after their menopause can help prevent loss of bone mass, reducing their risk of fractures, a Cochrane Review has found. This finding applies to women who have started to lose their bone mass but have no fractures (primary prevention), as well as those who have lost significant bone mass and/or have had fractures (secondary prevention).
Similar news · Read more »
Experts urge strongest isolation for new drug-resistant tuberculosis cases appearing in South Africa
01-22-2007 · EurekAlert!
Medical ethics and other experts say tough isolation measures, involuntary if need be, are justified to contain a very deadly, highly-contagious and drug-resistant mutant strains of tuberculosis and to prevent "a potentially explosive international health crisis" brewing most dangerously at the epicenter of South Africa's HIV/AIDS epidemic. The new TB variations now defeat many of the world's existing drugs and pose "extreme risk."
Similar news · Read more »
Forteo's bone-building power shown in arthritis patients
11-14-2007 · EurekAlert!
In a head-to-head comparison of the two drugs, Forteo increased lumbar spine density measurements by 7.2 percent compared to 3.4 percent for Fosamax, and it boosted hip density measurements by 3.8 percent compared to 2.4 percent for Fosamax. The study, by researchers at the University of Alabama at Birmingham, looked at changes in bone density over the course of 18 months in arthritis patients with prednisone-induced osteoporosis.
Similar news · Read more »
Women with osteoporosis, previous vertebral fracture have increased long-term risk for new fracture
12-18-2007 · EurekAlert!
Over a 15-year period, women with low bone mineral density and a previous vertebral fracture had an increased risk of a new vertebral fracture compared to women with normal bone mineral density and no previous fracture, according to a study in the Dec. 19 issue of JAMA.
Similar news · Read more »
Radioactive 'understudy' may aid medical imaging, drug development
01-09-2008 · EurekAlert!
Broadway stars have understudies. Now, an increasingly popular radioactive isotope has its own stand-in. Developed in part by researchers at the National Institute of Standards and Technology, the substance might ultimately improve medical imaging, speed up clinical trials of many drugs and facilitate efforts to develop more individualized medical treatment.
Similar news · Read more »
Cognitive impairment link found in older adults taking popular stomach acid medications
08-03-2007 · EurekAlert!
Long-term use of histamine2 receptor antagonists, one class of drugs that blocks stomach acid, may be associated with cognitive impairment in older African-American adults. According to an Indiana University School of Medicine and Regenstrief Institute study published in the August issue of the Journal of the American Geriatrics Society, the risk for showing signs of cognitive impairment is 2.5 times greater for patients using these medications long-term.
Similar news · Read more »
Bad to the bone: UD research to shed light on osteoporosis
11-15-2007 · EurekAlert!
Ten million people in the US are estimated to already have bone diseases, and almost 34 million more are estimated to have low bone mass, putting them at increased risk for osteoporosis, according to the National Osteoporosis Foundation. UD scientists are now leading research that will shed light on how osteocytes -- the cells encased inside your bones -- sense external stimuli and communicate with cells on the surface, signaling them to either build more bone or remove existing bone.
Similar news · Read more »